Tetrous, a company that specialises in regenerative medicine, has completed the first four surgeries using EnFix RC, a procedure-specific implant for rotator cuff repair, designed to address Enthesis Failure Syndrome. The enthesis is the site where a tendon, ligament, joint capsule, or fascia attaches to the bone.

Rotator cuff repairs are increasing. Between 2007 to 2016, 314,239 rotator cuff repairs were performed in the US. In about 20% of cases, these operations fail structurally.

Where the tendon does not effectively regrow to the bone there may be incomplete healing, gap formation and a high risk of re-tear. Therefore, reattaching the tendon is crucial, especially in the case of larger tears as failure rates increase with the size of the tear.

Most augmentation products are designed to reinforce the tendon. However, EnFix RC differs as it enhances healing at the enthesis where failure often occurs.

John Bojanowski, Tetrous’ Head of Sales and Marketing said:  “We are proud to offer a highly differentiated clinical solution. EnFix RC specifically promotes the remodelling of tissue approximating that of the natural tendon-bone interface, known as the enthesis. Tendon reattachment to the bone is a crucial clinical need, especially in larger tears, since failure rates increase linearly with tear size.”

The EnFix RC implant is made from demineralised cortical bone fibres. US-based Tetrous’ Bone Textile technology produces long and strong bone fibres to promote cell wicking, adhesion, and proliferation, and its FormLok technology promotes shape retention to the device.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The news comes just days after a rival company, Inovedis got FDA approval for its rotator cuff repair implant SINEFIX.